Gilead Sciences Settles Patent Dispute with U.S. Government Over HIV Drugs Truvada and Descovy
Gilead Sciences, the biopharmaceutical giant, has successfully settled a high-stakes patent dispute with the U.S. government concerning its HIV prevention
Continue Reading